Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

Philip Q. Bao, Ramesk K Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
JournalAnnals of Surgical Oncology
Volume18
Issue numberSUPPL. 3
DOIs
StatePublished - Dec 2011
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Erratum : Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9). / Bao, Philip Q.; Ramanathan, Ramesk K; Krasinkas, Alyssa; Bahary, Nathan; Lembersky, Barry C.; Bartlett, David L.; Hughes, Steven J.; Lee, Kenneth K.; James Moser, A.; Zeh, Herbert J.

In: Annals of Surgical Oncology, Vol. 18, No. SUPPL. 3, 12.2011.

Research output: Contribution to journalComment/debate

Bao, Philip Q. ; Ramanathan, Ramesk K ; Krasinkas, Alyssa ; Bahary, Nathan ; Lembersky, Barry C. ; Bartlett, David L. ; Hughes, Steven J. ; Lee, Kenneth K. ; James Moser, A. ; Zeh, Herbert J. / Erratum : Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9). In: Annals of Surgical Oncology. 2011 ; Vol. 18, No. SUPPL. 3.
@article{54bc97f699fe425cab845f33331dbe5d,
title = "Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)",
author = "Bao, {Philip Q.} and Ramanathan, {Ramesk K} and Alyssa Krasinkas and Nathan Bahary and Lembersky, {Barry C.} and Bartlett, {David L.} and Hughes, {Steven J.} and Lee, {Kenneth K.} and {James Moser}, A. and Zeh, {Herbert J.}",
year = "2011",
month = "12",
doi = "10.1245/s10434-011-1681-8",
language = "English (US)",
volume = "18",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Erratum

T2 - Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

AU - Bao, Philip Q.

AU - Ramanathan, Ramesk K

AU - Krasinkas, Alyssa

AU - Bahary, Nathan

AU - Lembersky, Barry C.

AU - Bartlett, David L.

AU - Hughes, Steven J.

AU - Lee, Kenneth K.

AU - James Moser, A.

AU - Zeh, Herbert J.

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=82955182169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955182169&partnerID=8YFLogxK

U2 - 10.1245/s10434-011-1681-8

DO - 10.1245/s10434-011-1681-8

M3 - Comment/debate

AN - SCOPUS:82955182169

VL - 18

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - SUPPL. 3

ER -